Loading...
No images? Click here Thursday, 23 February 2023 Virtual Press Conference WHO Recommendation on the
WHAT: From 20-23 February 2023, WHO organized a four-day consultation with an advisory group of experts, to generate the recommendations on the Composition of Influenza Virus Vaccines for Use in the 2023-2024 Northern Hemisphere Influenza Season. These recommendations are used by the national vaccine regulatory agencies and the pharmaceutical companies to develop, produce and license influenza vaccines. On Friday, 24 February 2023, WHO will then hold a virtual Information Meeting on the recommendations for representatives and individuals from vaccine regulatory agencies, influenza vaccine manufacturers, members of the WHO Global Influenza Surveillance and Response System (GISRS), and other interested institutions. You are welcome to follow the Information Meeting on Zoom from 10.00-12.30 CET. Connect: ZOOM Password: VCMFEB@23 This will be followed by a Global Virtual Press Conference where the recommendation will be discussed. WHEN: Virtual Press ConferenceFriday, 24 February 2022 13:00-14:00 / 1pm-2:pm CET (Geneva time) https://who.zoom.us/j/98356400483 (no password required)
SPEAKERS: Dr Sylvie BRIAND, Director, WHO Director, Epidemic and Pandemic Preparedness and PreventionDr Wenqing ZHANG, Head, WHO Global Influenza Programme (GIP)Dr Franceso BONFANTE Expert, FAO, WOAH and OFFLUDr Kanta SUBBARAO, Director, WHO Collaborating Centre for Reference and Research on Influenza, Victoria Infectious Diseases Reference Laboratory (VIDRL), AustraliaDr David WENTWORTH, Director, WHO Collaborating Centre for the Surveillance, Epidemiology and Control of Influenza, Centers for Disease Control and Prevention (CDC), USADr Richard WEBBY, Director, WHO Collaborating Centre for Studies on the Ecology of Influenza in Animals, Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, USA
NOTES FOR JOURNALISTS: Media contacts: You are receiving this NO-REPLY email because you are included on a WHO mail list.
|
Loading...
Loading...